Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	sulfonylurea receptor activity	ABCC8 ABCC9	6.14e-06	2	50	2	GO:0008281
GeneOntologyMolecularFunction	ATP-activated inward rectifier potassium channel activity	ABCC8 ABCC9	9.16e-05	6	50	2	GO:0015272
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA2 PHF2 NRIP1 KAT6A TAF5L KAT6B	1.05e-04	303	50	6	GO:0003713
GeneOntologyMolecularFunction	histone H3K14 acetyltransferase activity	KAT6A KAT6B	2.19e-04	9	50	2	GO:0036408
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	KAT6A KAT6B	6.32e-04	15	50	2	GO:0010484
GeneOntologyCellularComponent	potassium ion-transporting ATPase complex	ABCC8 ABCC9	1.68e-05	3	50	2	GO:0031004
GeneOntologyCellularComponent	inward rectifying potassium channel	ABCC8 ABCC9	3.35e-05	4	50	2	GO:0008282
GeneOntologyCellularComponent	MOZ/MORF histone acetyltransferase complex	KAT6A KAT6B	1.17e-04	7	50	2	GO:0070776
GeneOntologyCellularComponent	H3 histone acetyltransferase complex	KAT6A KAT6B	1.56e-04	8	50	2	GO:0070775
GeneOntologyCellularComponent	nuclear body	NCOA2 NRIP1 RAD18 KAT6A SMU1 PLCB1 TAF5L POU2F3 GNL3	2.56e-04	903	50	9	GO:0016604
GeneOntologyCellularComponent	histone acetyltransferase complex	KAT6A TAF5L KAT6B	1.48e-03	94	50	3	GO:0000123
GeneOntologyCellularComponent	protein acetyltransferase complex	KAT6A TAF5L KAT6B	1.98e-03	104	50	3	GO:0031248
GeneOntologyCellularComponent	apicolateral plasma membrane	CLDN3 MTCL1	2.04e-03	28	50	2	GO:0016327
GeneOntologyCellularComponent	acetyltransferase complex	KAT6A TAF5L KAT6B	2.26e-03	109	50	3	GO:1902493
GeneOntologyCellularComponent	chromatin	NCOA2 TRIM33 NRIP1 RAD18 KAT6A PLCB1 TAF5L KAT6B POU2F3 RXRG	2.32e-03	1480	50	10	GO:0000785
Domain	PHD	PHF2 TRIM33 INTS12 KAT6A KAT6B	1.36e-06	75	48	5	PF00628
Domain	Znf_PHD-finger	PHF2 TRIM33 INTS12 KAT6A KAT6B	1.77e-06	79	48	5	IPR019787
Domain	Znf_FYVE_PHD	PHF2 TRIM33 INTS12 FGD4 KAT6A KAT6B	2.01e-06	147	48	6	IPR011011
Domain	PHD	PHF2 TRIM33 INTS12 KAT6A KAT6B	3.20e-06	89	48	5	SM00249
Domain	Znf_PHD	PHF2 TRIM33 INTS12 KAT6A KAT6B	3.57e-06	91	48	5	IPR001965
Domain	ZF_PHD_2	PHF2 TRIM33 INTS12 KAT6A KAT6B	4.41e-06	95	48	5	PS50016
Domain	ZF_PHD_1	PHF2 TRIM33 INTS12 KAT6A KAT6B	4.64e-06	96	48	5	PS01359
Domain	Sulphorea_rcpt	ABCC8 ABCC9	6.47e-06	2	48	2	IPR000388
Domain	MOZ_SAS	KAT6A KAT6B	6.44e-05	5	48	2	PF01853
Domain	HAT_MYST-type	KAT6A KAT6B	6.44e-05	5	48	2	IPR002717
Domain	MYST_HAT	KAT6A KAT6B	6.44e-05	5	48	2	PS51726
Domain	-	PHF2 TRIM33 RAD18 INTS12 FGD4 KAT6A KAT6B	1.39e-04	449	48	7	3.30.40.10
Domain	Znf_RING/FYVE/PHD	PHF2 TRIM33 RAD18 INTS12 FGD4 KAT6A KAT6B	1.59e-04	459	48	7	IPR013083
Domain	H15	KAT6A KAT6B	4.95e-04	13	48	2	SM00526
Domain	H15	KAT6A KAT6B	4.95e-04	13	48	2	PS51504
Domain	Histone_H1/H5_H15	KAT6A KAT6B	5.77e-04	14	48	2	IPR005818
Domain	Zinc_finger_PHD-type_CS	PHF2 TRIM33 INTS12	6.22e-04	65	48	3	IPR019786
Domain	SEA	UMODL1 MUC17	1.45e-03	22	48	2	PF01390
Domain	SEA	UMODL1 MUC17	1.58e-03	23	48	2	PS50024
Domain	SEA_dom	UMODL1 MUC17	1.58e-03	23	48	2	IPR000082
Domain	ABC_membrane	ABCC8 ABCC9	1.72e-03	24	48	2	PF00664
Domain	ABC_TM1F	ABCC8 ABCC9	2.34e-03	28	48	2	PS50929
Domain	ABC1_TM_dom	ABCC8 ABCC9	2.34e-03	28	48	2	IPR011527
Domain	UQ_con	UBE2V2 BIRC6	4.51e-03	39	48	2	PF00179
Domain	-	KAT6A KAT6B	4.74e-03	40	48	2	3.40.630.30
Domain	UBIQUITIN_CONJUGAT_1	UBE2V2 BIRC6	4.74e-03	40	48	2	PS00183
Domain	UBQ-conjugat_E2	UBE2V2 BIRC6	4.98e-03	41	48	2	IPR000608
Domain	UBIQUITIN_CONJUGAT_2	UBE2V2 BIRC6	4.98e-03	41	48	2	PS50127
Domain	ABC_transporter_CS	ABCC8 ABCC9	5.22e-03	42	48	2	IPR017871
Domain	Acyl_CoA_acyltransferase	KAT6A KAT6B	5.97e-03	45	48	2	IPR016181
Domain	ABC_tran	ABCC8 ABCC9	6.77e-03	48	48	2	PF00005
Domain	ABC_TRANSPORTER_2	ABCC8 ABCC9	6.77e-03	48	48	2	PS50893
Domain	ABC_TRANSPORTER_1	ABCC8 ABCC9	7.04e-03	49	48	2	PS00211
Domain	ABC_transporter-like	ABCC8 ABCC9	7.32e-03	50	48	2	IPR003439
Domain	-	UBE2V2 BIRC6	7.61e-03	51	48	2	3.10.110.10
Pubmed	Human transcription factor protein interaction networks.	NCOA2 PHF2 TET2 TRIM33 RAD18 INTS12 DNAJA2 DDX18 CCT7 USP46 HADHB TAF5L GNL3	7.73e-08	1429	50	13	35140242
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PHF2 TRIM33 RAD18 ZNF460 DNAJA2 DDX18 KAT6A CAPRIN2 TAF5L KAT6B GNL3	4.19e-07	1116	50	11	31753913
Pubmed	Promoter DNA methylation regulates murine SUR1 (Abcc8) and SUR2 (Abcc9) expression in HL-1 cardiomyocytes.	ABCC8 ABCC9	2.03e-06	2	50	2	22844491
Pubmed	Expression of the MOZ-TIF2 oncoprotein in mice represses senescence.	NCOA2 KAT6A	2.03e-06	2	50	2	26854485
Pubmed	Molecular determinants of ATP-sensitive potassium channel MgATPase activity: diabetes risk variants and diazoxide sensitivity.	ABCC8 ABCC9	2.03e-06	2	50	2	26181369
Pubmed	Regulation of KAT6 Acetyltransferases and Their Roles in Cell Cycle Progression, Stem Cell Maintenance, and Human Disease.	KAT6A KAT6B	2.03e-06	2	50	2	27185879
Pubmed	Complex consequences of Cantu syndrome SUR2 variant R1154Q in genetically modified mice.	ABCC8 ABCC9	2.03e-06	2	50	2	33529173
Pubmed	A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.	NCOA2 KAT6A	2.03e-06	2	50	2	9558366
Pubmed	ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B.	KAT6A KAT6B	2.03e-06	2	50	2	39505971
Pubmed	The double PHD finger domain of MOZ/MYST3 induces α-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification.	KAT6A KAT6B	2.03e-06	2	50	2	24150941
Pubmed	Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells.	NCOA2 NRIP1 RXRG	4.85e-06	23	50	3	19737349
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	NCOA2 PHF2 DNAJA2 SMU1 CCT7 MTCL1 HADHB TAF5L CNN3	5.88e-06	922	50	9	27609421
Pubmed	MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain.	KAT6A KAT6B	6.07e-06	3	50	2	36754959
Pubmed	Functional roles of KATP channel subunits in metabolic inhibition.	ABCC8 ABCC9	6.07e-06	3	50	2	23624089
Pubmed	Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin.	KAT6A KAT6B	6.07e-06	3	50	2	23063713
Pubmed	A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.	ABCC8 ABCC9	6.07e-06	3	50	2	8630239
Pubmed	MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.	NCOA2 KAT6A	6.07e-06	3	50	2	12676584
Pubmed	Systematic Affinity Purification Coupled to Mass Spectrometry Identified p62 as Part of the Cannabinoid Receptor CB2 Interactome.	SELENOT DHRS7 DNAJA2 HADHB	6.70e-06	84	50	4	31616248
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TET2 TRIM33 CELSR3 CAPRIN2 EFR3B PLCB1 KAT6B	1.03e-05	529	50	7	14621295
Pubmed	MOZ-TIF2 alters cofactor recruitment and histone modification at the RARbeta2 promoter: differential effects of MOZ fusion proteins on CBP- and MOZ-dependent activators.	NCOA2 KAT6A	1.21e-05	4	50	2	16613851
Pubmed	The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60.	KAT6A KAT6B	1.21e-05	4	50	2	17980166
Pubmed	KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer.	TRIM33 KAT6A	1.21e-05	4	50	2	34392614
Pubmed	Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.	NCOA2 KAT6A	1.21e-05	4	50	2	24258712
Pubmed	Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells.	NCOA2 NRIP1	1.21e-05	4	50	2	15331759
Pubmed	Assembly limits the pharmacological complexity of ATP-sensitive potassium channels.	ABCC8 ABCC9	1.21e-05	4	50	2	11825905
Pubmed	A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel.	ABCC8 ABCC9	1.21e-05	4	50	2	8798681
Pubmed	Deoxyribonucleic acid response element-dependent regulation of transcription by orphan nuclear receptor estrogen receptor-related receptor gamma.	NCOA2 NRIP1	1.21e-05	4	50	2	14645497
Pubmed	Expression of mRNA transcripts for ATP-sensitive potassium channels in human myometrium.	ABCC8 ABCC9	1.21e-05	4	50	2	12356945
Pubmed	Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).	KAT6A KAT6B	1.21e-05	4	50	2	21880731
Pubmed	Expression of ATP-sensitive K+ channel subunits during perinatal maturation in the mouse heart.	ABCC8 ABCC9	1.21e-05	4	50	2	16085792
Pubmed	MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.	NCOA2 KAT6A	1.21e-05	4	50	2	17697320
Pubmed	Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons.	ABCC8 ABCC9	1.21e-05	4	50	2	10022826
Pubmed	Conserved functional consequences of disease-associated mutations in the slide helix of Kir6.1 and Kir6.2 subunits of the ATP-sensitive potassium channel.	ABCC8 ABCC9	1.21e-05	4	50	2	28842488
Pubmed	Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication.	KAT6A KAT6B	2.02e-05	5	50	2	17182677
Pubmed	Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription.	NCOA2 RXRG	2.02e-05	5	50	2	15919723
Pubmed	MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2.	KAT6A KAT6B	2.02e-05	5	50	2	11965546
Pubmed	Synthetic retinoids dissociate coactivator binding from corepressor release.	NCOA2 NRIP1	2.02e-05	5	50	2	12503607
Pubmed	MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.	NCOA2 KAT6A	2.02e-05	5	50	2	15657427
Pubmed	Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination.	RAD18 UBE2V2	2.02e-05	5	50	2	18316726
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOA2 TET2 TRIM33 NRIP1 HADHB TAF5L	2.25e-05	398	50	6	35016035
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 PHF2 TET2 TRIM33 INTS12 SMU1 CCT7 HADHB TAF5L	2.44e-05	1103	50	9	34189442
Pubmed	Ankyrin-B regulates Kir6.2 membrane expression and function in heart.	ABCC8 ABCC9	3.03e-05	6	50	2	20610380
Pubmed	Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent polyubiquitylation of proliferating cell nuclear antigen.	RAD18 UBE2V2	3.03e-05	6	50	2	17108083
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	TRIM33 DNAJA2 DDX18 SMU1 CCT7 HADHB GNL3	3.41e-05	638	50	7	33239621
Pubmed	Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.	KAT6A KAT6B	4.23e-05	7	50	2	18794358
Pubmed	Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.	UBE2V2 TICAM1	4.23e-05	7	50	2	20047764
Pubmed	The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.	NCOA2 RXRG	5.64e-05	8	50	2	12082103
Pubmed	ATP-sensitive potassium channels mediate survival during infection in mammals and insects.	TICAM1 ABCC9	5.64e-05	8	50	2	18026101
Pubmed	Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.	NCOA2 NRIP1	5.64e-05	8	50	2	9774463
Pubmed	En bloc transfer of polyubiquitin chains to PCNA in vitro is mediated by two different human E2-E3 pairs.	RAD18 UBE2V2	5.64e-05	8	50	2	22904075
Pubmed	New nomenclature for chromatin-modifying enzymes.	NCOA2 KAT6A KAT6B	7.74e-05	57	50	3	18022353
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NCOA2 TET2 TRIM33 NRIP1 CELSR3 DNAJA2 DDX18 CCT7 RXRG	7.97e-05	1285	50	9	35914814
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	PHF2 RAD18 INTS12 DNAJA2 DDX18 SMU1 HADHB TAF5L GNL3	8.41e-05	1294	50	9	30804502
Pubmed	Large-scale analysis of the human ubiquitin-related proteome.	RAD18 DNAJA2 DDX18 HADHB BIRC6	8.69e-05	313	50	5	16196087
Pubmed	Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.	NCOA2 NRIP1	9.05e-05	10	50	2	15001550
Pubmed	The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.	TET2 DNAJA2 CCT7 HADHB CNN3	1.08e-04	328	50	5	23398456
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 NRIP1	1.10e-04	11	50	2	36613751
Pubmed	Acetylation of HIV-1 integrase by p300 regulates viral integration.	KAT6A KAT6B	1.10e-04	11	50	2	16096645
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	DDX18 KAT6A SMU1 CCT7 GNL3	1.11e-04	330	50	5	33301849
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	TET2 DNAJA2 SMU1 CCT7 HADHB GNL3	1.35e-04	551	50	6	34728620
Pubmed	Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140.	NCOA2 NRIP1	1.56e-04	13	50	2	11266503
Pubmed	Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells.	TICAM1 UNC13D	1.82e-04	14	50	2	26720279
Pubmed	Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.	NCOA2 NRIP1	1.82e-04	14	50	2	11500849
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NCOA2 TRIM33 NRIP1 RAD18 INTS12 DNAJA2	1.92e-04	588	50	6	38580884
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	NCOA2 NRIP1 CAPRIN2 CCT7	2.31e-04	208	50	4	33230847
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PHF2 TRIM33 INTS12 FGD4 SMU1 CCT7 CLDN3 TAF5L GNL3	2.51e-04	1497	50	9	31527615
Pubmed	The protein composition of mitotic chromosomes determined using multiclassifier combinatorial proteomics.	PHF2 DDX18	2.72e-04	17	50	2	20813266
Pubmed	Localization of the mouse glucocorticoid receptor-interacting protein 1 gene (Grip1) to proximal chromosome 1 by linkage analysis.	NCOA2 RXRG	2.72e-04	17	50	2	9250876
Pubmed	A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication.	INTS12 SMU1 CLDN3 IL6ST	2.76e-04	218	50	4	19460752
Pubmed	The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.	RAD18 DNAJA2 HADHB GNL3	2.86e-04	220	50	4	34091597
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	NCOA2 TRIM33 SMU1 GNL3	2.86e-04	220	50	4	35785414
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PHF2 PLCB1 KAT6B BIRC6	3.11e-04	225	50	4	12168954
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	TRIM33 INTS12 CELSR3 GNL3	3.44e-04	231	50	4	36597993
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	DNAJA2 DDX18 CCT7 HADHB GNL3 CNN3	3.71e-04	665	50	6	30457570
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	DDX18 SMU1 CCT7 HADHB GNL3	3.78e-04	430	50	5	38172120
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA2 NRIP1	3.79e-04	20	50	2	11877444
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA2 NRIP1	4.18e-04	21	50	2	19596656
Pubmed	Negative modulation of androgen receptor transcriptional activity by Daxx.	NCOA2 NRIP1	4.59e-04	22	50	2	15572661
Pubmed	Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus.	ABCC8 ABCC9	5.03e-04	23	50	2	10708515
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	TET2 DNAJA2 DDX18 CCT7 HADHB GNL3	5.29e-04	711	50	6	33022573
Pubmed	E-cadherin is required for intestinal morphogenesis in the mouse.	MUC17 CLDN3	5.48e-04	24	50	2	22766025
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TRIM33 RAD18 DNAJA2 DDX18 SMU1 CCT7 GNL3	5.87e-04	1014	50	7	32416067
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 TET2 TRIM33 INTS12	6.01e-04	268	50	4	33640491
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	KAT6A PLCB1 USP46 TAF5L KAT6B GNL3	6.07e-04	730	50	6	34857952
Pubmed	Replication of a genome-wide case-control study of esophageal squamous cell carcinoma.	PLCB1 MTCL1	6.95e-04	27	50	2	18649358
Pubmed	SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption.	DNAJA2 CCT7 HADHB	6.98e-04	120	50	3	37929963
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PHF2 DNAJA2 EFR3B CCT7 USP46 HADHB BIRC6	7.17e-04	1049	50	7	27880917
Pubmed	Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action.	NCOA2 NRIP1	7.48e-04	28	50	2	24880616
Pubmed	A genetic linkage map of mouse chromosome 2 extending from thrombospondin to paired box gene 1, including the H3 minor histocompatibility complex.	SLC12A1 PLCB1	8.02e-04	29	50	2	8617512
Pubmed	γ-Linolenic acid in maternal milk drives cardiac metabolic maturation.	HADHB RXRG	8.59e-04	30	50	2	37225978
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	DNAJA2 DDX18 SMU1 CCT7 MTCL1 HADHB BIRC6 GNL3	8.62e-04	1415	50	8	28515276
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	PHF2 DNAJA2 DDX18 SMU1 CCT7 HADHB TAF5L GNL3	9.03e-04	1425	50	8	30948266
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TET2 NRIP1 USP46 KAT6B CNN3	1.02e-03	536	50	5	15840001
Pubmed	Tet2- and Tet3- Mediated Cytosine Hydroxymethylation in Six2 Progenitor Cells in Mice Is Critical for Nephron Progenitor Differentiation and Nephron Endowment.	TET2 SLC12A1	1.04e-03	33	50	2	36522157
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SELENOT DHRS7 DNAJA2 DDX18 SMU1 EFR3B HADHB GNL3	1.19e-03	1487	50	8	33957083
Pubmed	Hnf1b haploinsufficiency differentially affects developmental target genes in a new renal cysts and diabetes mouse model.	SLC12A1 SLC3A1	1.24e-03	36	50	2	33737325
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RAD18 ZNF460 DNAJA2 CCT7 MTCL1 HADHB GNL3	1.26e-03	1155	50	7	20360068
Pubmed	TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A.	DNAJA2 CCT7	1.31e-03	37	50	2	29531219
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	INTS12 DNAJA2 CCT7 MTCL1 HADHB	1.37e-03	573	50	5	28330616
Pubmed	Tagging genes with cassette-exchange sites.	TAF5L KAT6B BIRC6 GNL3	1.37e-03	335	50	4	15741177
GeneFamily	PHD finger proteins	PHF2 TRIM33 INTS12 KAT6A KAT6B	1.20e-06	90	38	5	88
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 KAT6A KAT6B	5.71e-06	17	38	3	486
GeneFamily	ATP binding cassette subfamily C	ABCC8 ABCC9	3.31e-04	13	38	2	807
GeneFamily	Zinc fingers C2HC-type\|PHD finger proteins\|Lysine acetyltransferases	KAT6A KAT6B	5.07e-04	16	38	2	66
GeneFamily	Ubiquitin conjugating enzymes E2	UBE2V2 BIRC6	3.35e-03	41	38	2	102
Drug	AC1L9EU8	DHRS7 KAT6A KAT6B	3.57e-06	14	50	3	CID000443526
Drug	AC1LCVO5	DHRS7 KAT6A KAT6B	3.57e-06	14	50	3	CID000656890
Drug	Phlorhizin	UBE2V2 DNAJA2 CCT7 USP46 HADHB BIRC6	1.23e-05	235	50	6	ctd:D010695
Drug	AC1L38YU	NCOA2 ABCC8 DNAJA2 KAT6A	2.74e-05	79	50	4	CID000085196
Drug	sulfosuccinate	ABCC8 GNL3	2.83e-05	4	50	2	CID000021220
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 USP46 KAT6B	3.15e-05	166	50	5	2247_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 USP46 KAT6B	3.43e-05	169	50	5	5231_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	NCOA2 PHF2 NRIP1 USP46 KAT6B	3.63e-05	171	50	5	1000_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	NCOA2 TRIM33 NRIP1 MTCL1 KAT6B	3.63e-05	171	50	5	7535_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	PHF2 NRIP1 CLDN3 USP46 KAT6B	3.63e-05	171	50	5	6879_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 USP46 KAT6B	3.63e-05	171	50	5	4954_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 PHF2 NRIP1 USP46 KAT6B	3.74e-05	172	50	5	1072_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 USP46 KAT6B	3.95e-05	174	50	5	3462_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 USP46 KAT6B	3.95e-05	174	50	5	5580_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 CLDN3 KAT6B	4.17e-05	176	50	5	2639_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 NRIP1 USP46 TAF5L KAT6B	4.40e-05	178	50	5	5086_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA2 PHF2 NRIP1 USP46 KAT6B	4.40e-05	178	50	5	1112_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 USP46 KAT6B	4.64e-05	180	50	5	6886_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	TRIM33 NRIP1 KAT6A MTCL1 KAT6B	4.64e-05	180	50	5	4541_DN
Drug	SAHA; Down 200; 10uM; HL60; HT_HG-U133A	NCOA2 PHF2 XAF1 USP46 KAT6B	4.64e-05	180	50	5	2680_DN
Drug	thioformamide	ABCC8 ABCC9	4.71e-05	5	50	2	CID003005587
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 USP46 KAT6B	4.76e-05	181	50	5	6951_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 USP46 KAT6B	5.02e-05	183	50	5	4770_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 USP46 KAT6B	5.42e-05	186	50	5	6874_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	TRIM33 NRIP1 TICAM1 MTCL1 KAT6B	5.42e-05	186	50	5	916_DN
Drug	AC1L2E0P	NCOA2 TRIM33 NRIP1 KAT6A KAT6B RXRG	5.52e-05	307	50	6	CID000019390
Drug	trimetazidine	HADHB BIRC6 GNL3	5.68e-05	34	50	3	CID000021109
Drug	Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	NCOA2 PLCB1 MTCL1 IL6ST SLC3A1	6.78e-05	195	50	5	5447_DN
Drug	2-methylbutyryl-CoA	KAT6A HADHB KAT6B	7.35e-05	37	50	3	CID000000054
Drug	Glyburide	ABCC8 ABCC9	1.31e-04	8	50	2	DB01016
Drug	AC1LCVO8	KAT6A KAT6B	1.31e-04	8	50	2	CID000656891
Drug	2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3	NCOA2 NRIP1	2.57e-04	11	50	2	ctd:C061137
Drug	C04424	KAT6A KAT6B	2.57e-04	11	50	2	CID011953835
Drug	AC1L986B	ABCC8 SLC3A1	2.57e-04	11	50	2	CID000439854
Drug	3-Hydroxybutanoyl-Coenzyme A	KAT6A HADHB KAT6B	2.68e-04	57	50	3	CID000000521
Drug	C05118	KAT6A KAT6B	3.08e-04	12	50	2	CID000440565
Drug	C05119	KAT6A KAT6B	3.08e-04	12	50	2	CID000440566
Drug	dihydroxy-vitamin D3	NCOA2 NRIP1	3.63e-04	13	50	2	ctd:C118756
Drug	AC1L9EUB	KAT6A KAT6B	3.63e-04	13	50	2	CID000443527
Drug	AC1L1A2K	KAT6A HADHB KAT6B	4.14e-04	66	50	3	CID000000808
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.31e-04	161	50	4	4768_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.51e-04	163	50	4	5594_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.51e-04	163	50	4	7453_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.62e-04	164	50	4	4388_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.72e-04	165	50	4	6085_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.72e-04	165	50	4	5625_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.72e-04	165	50	4	2835_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.83e-04	166	50	4	7324_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.94e-04	167	50	4	5217_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	4.94e-04	167	50	4	3979_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.06e-04	168	50	4	3868_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.06e-04	168	50	4	6820_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.17e-04	169	50	4	5572_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.17e-04	169	50	4	6064_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.29e-04	170	50	4	4153_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA2 PHF2 NRIP1 KAT6B	5.29e-04	170	50	4	1050_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.29e-04	170	50	4	5417_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.29e-04	170	50	4	7043_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.29e-04	170	50	4	5260_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PHF2 NRIP1 USP46 KAT6B	5.40e-04	171	50	4	7407_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PHF2 NRIP1 USP46 KAT6B	5.40e-04	171	50	4	2777_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.40e-04	171	50	4	5441_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.40e-04	171	50	4	1234_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.52e-04	172	50	4	7179_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.52e-04	172	50	4	3428_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.52e-04	172	50	4	2330_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.52e-04	172	50	4	1637_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.52e-04	172	50	4	6993_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.52e-04	172	50	4	2794_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.52e-04	172	50	4	5903_DN
Drug	(2R)-2-amino-5-[[amino-(2-methoxyethylamino)methylene]amino]valeric acid	CLDN3 SLC3A1	5.56e-04	16	50	2	CID011287714
Drug	NN414	ABCC8 ABCC9	5.56e-04	16	50	2	CID000219048
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.65e-04	173	50	4	4665_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.65e-04	173	50	4	5987_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.65e-04	173	50	4	5950_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.65e-04	173	50	4	5336_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.65e-04	173	50	4	3243_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.77e-04	174	50	4	7105_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.77e-04	174	50	4	6579_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.77e-04	174	50	4	5745_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.77e-04	174	50	4	1659_DN
Drug	HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA2 PHF2 NRIP1 KAT6B	5.77e-04	174	50	4	909_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.77e-04	174	50	4	5945_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.77e-04	174	50	4	5693_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PHF2 NRIP1 USP46 KAT6B	5.77e-04	174	50	4	6493_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.77e-04	174	50	4	5940_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.77e-04	174	50	4	5065_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 NRIP1 CLDN3 KAT6B	5.89e-04	175	50	4	6316_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.89e-04	175	50	4	5935_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 PHF2 NRIP1 KAT6B	5.89e-04	175	50	4	1014_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	NCOA2 PHF2 NRIP1 KAT6B	5.89e-04	175	50	4	1058_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.89e-04	175	50	4	7387_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.89e-04	175	50	4	3787_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.89e-04	175	50	4	7236_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	5.89e-04	175	50	4	6891_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	6.02e-04	176	50	4	3312_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	6.02e-04	176	50	4	7499_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 PHF2 NRIP1 KAT6B	6.02e-04	176	50	4	981_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	6.02e-04	176	50	4	6546_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 NRIP1 KAT6B	6.02e-04	176	50	4	6932_DN
Disease	Malignant neoplasm of breast	NCOA2 NRIP1 TICAM1 DDX18 SLC10A6 PLCB1 HADHB KAT6B NLRP8	6.00e-05	1074	49	9	C0006142
Disease	Prostatic Neoplasms	NCOA2 TET2 KAT6A UNC13D CLDN3 CNN3 IL6ST	6.71e-05	616	49	7	C0033578
Disease	Malignant neoplasm of prostate	NCOA2 TET2 KAT6A UNC13D CLDN3 CNN3 IL6ST	6.71e-05	616	49	7	C0376358
Disease	hemoglobin A1 measurement	TET2 GPR155 UBE2V2 ABCC8 PLCB1 UNC13D	2.14e-04	520	49	6	EFO_0007629
Disease	health study participation	PHF2 TET2 CELSR3 BIRC6	3.11e-04	195	49	4	EFO_0010130
Disease	acute myeloid leukemia (is_implicated_in)	NCOA2 TET2 KAT6A	3.73e-04	84	49	3	DOID:9119 (is_implicated_in)
Disease	vital capacity	TET2 RAD18 INTS12 CAPRIN2 EFR3B PLCB1 UNC13D MTCL1	9.05e-04	1236	49	8	EFO_0004312
Disease	Hematopoetic Myelodysplasia	TET2 PLCB1	1.07e-03	29	49	2	C2713368
Disease	myelodysplastic syndrome (is_implicated_in)	TET2 PLCB1	1.14e-03	30	49	2	DOID:0050908 (is_implicated_in)
Disease	Colorectal Neoplasms	TET2 ABCC8 XAF1 IL6ST	1.16e-03	277	49	4	C0009404
Disease	mean platelet volume	TET2 FGD4 PLCB1 KIF28P UNC13D CLDN3 HADHB	1.40e-03	1020	49	7	EFO_0004584
Disease	Parkinsonism (biomarker_via_orthology)	ABCC8 ABCC9	1.46e-03	34	49	2	DOID:0080855 (biomarker_via_orthology)
Disease	age at menopause	NCOA2 RAD18 BIRC6 RXRG	1.59e-03	302	49	4	EFO_0004704
Disease	lung non-small cell carcinoma (is_implicated_in)	NCOA2 TET2 RXRG	1.61e-03	139	49	3	DOID:3908 (is_implicated_in)
Disease	ascending aortic diameter	ABCC8 ABCC9 UNC13D	1.64e-03	140	49	3	EFO_0021787
Disease	pulmonary function measurement, forced expiratory volume	TET2 INTS12	1.73e-03	37	49	2	EFO_0003892, EFO_0004314

Protein segments in the cluster

Peptide	Gene	Start	Entry
SECGTLMQSNMTNTV	UMODL1	1041	Q5DID0
MGGVQLICNNMVTST	BIRC6	3101	Q9NR09
SNLSMGEMTLGQINN	ABCC9	401	O60706
VNNGGMSQRSLCMDT	DHRS7	136	Q9Y394
MACISANQAMTTGVG	HADHB	136	P55084
SVCMGQEDNMTSVTN	RAD18	386	Q9NS91
MACQTNGSRTMGTQT	MTCL1	1626	Q9Y4B5
RQMMVASGNQLVECQ	INTS12	166	Q96CB8
VTQQMSNISGSCSML	KAT6B	1721	Q8WYB5
MVCSGLKQQMERGNN	NLRP8	401	Q86W28
GISLMCMNQTAQAGS	GPR155	536	Q7Z3F1
GMQNMTVVISGLCNV	ASAH2	561	Q9NR71
LQVSTGFQCNNMMSA	EFR3B	436	Q9Y2G0
QTCVANGVMAAQNQM	FGD4	86	Q96M96
LQNLAQCGMQSSMSV	NRIP1	631	P48552
MNVGLSETQNGGMSQ	DDX18	61	Q9NVP1
QMSGLNASPCQDMAS	POU2F3	76	Q9UKI9
CSMMQQSSVQPAANC	KAT6A	1616	Q92794
PGMVQQMQSVCSDCN	DNAJA2	176	O60884
ISQSCGSGQMKMFQE	IL6ST	856	P40189
QDLMTQIQGTCNFMQ	CAPRIN2	621	Q6IMN6
QEQMCNVGVSMGLTR	GNL3	276	Q9BVP2
GGQMMTSIDNQTLCG	KLF18	221	A0A0U1RQI7
MTSTGNQNLCGEQVM	KLF18	351	A0A0U1RQI7
MMTSTGNQNLCGEQV	KLF18	406	A0A0U1RQI7
MTSTGNQALCGGQMT	KLF18	421	A0A0U1RQI7
QMMTSTGNQNLCGEQ	KLF18	741	A0A0U1RQI7
MAAFVANNGTMAGCQ	CELSR3	1706	Q9NYQ7
AQLPSAGEMSQMCTQ	KIF28P	881	B7ZC32
AGEMSQMCTQQAGSD	KIF28P	886	B7ZC32
SDMMCFNTTGTQVQN	MUC17	4291	Q685J3
GQMSNVLSVQFMACN	TAF5L	561	O75529
SNMIENQCMSTGAFE	SELENOT	136	P62341
SVQTMQRGNMNCGAF	TRIM33	571	Q9UPN9
QGMLSMANLQASDSC	PHF2	796	O75151
IEMSMKGCQTNNGFV	SLC3A1	11	Q07837
ATGNMNDTIISGMNC	SLC12A1	441	Q13621
RTMMACGGSIQTSVN	CCT7	321	Q99832
NLSMGEMTAGQICNL	ABCC8	406	Q09428
MNCVVQSTGQMQCKV	CLDN3	51	O15551
LQMGTNKCASQAGMT	CNN3	166	Q15417
NNMNINVSMATNTGG	NCOA2	1386	Q15596
QAVINTMCGQGMQAF	TSPAN33	196	Q86UF1
TADGICSMMIQNQVS	ZNF460	131	Q14592
CNRSNTVVIMNMQGQ	SMU1	416	Q2TAY7
QAMMSNLTRQGSPDC	TICAM1	471	Q8IUC6
QVGCTMCQQSMQKSS	XAF1	56	Q6GPH4
MNMENSTNDPVTNIC	RXRG	256	P48443
ETGAQNIQMCITMLQ	SLC10A6	261	Q3KNW5
NAGCQMVALNFQTMD	PLCB1	616	Q9NQ66
MTVRNIASICNMGTN	USP46	1	P62068
INMNGINNSSGMVDA	UBE2V2	86	Q15819
SQMYQVEMNQGQSQG	TET2	631	Q6N021
NNCAVQSMEMSFVTG	ZNF772	211	Q68DY9
QGQAANMLCVVVNDM	UNC13D	691	Q70J99